{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000612","form_type":"8-K/A","ticker":"MRAI","cik":"0001844392","company_name":"Marpai, Inc.","filed_at":"2023-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.083389+00:00","generated_at":"2026-06-20T17:15:17.788107+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Marpai files Maestro Health financials; acquired co. net loss $29.3M in 2021","bullets":["Maestro Health 2021 revenue $19.4M, net loss $29.3M; members' deficit $35.1M as of Dec 31, 2021.","Unaudited nine-month 2022 financial statements included; acquisition closed Nov 1, 2022.","Pro forma combined financials filed; Maestro Health reports going concern with AXA support through May 2023.","Marpai acquired Maestro Health via membership interest purchase; no deal value disclosed in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000612","json":"https://secwatch.observer/filing/0000950170-23-000612.json","markdown":"https://secwatch.observer/filing/0000950170-23-000612.md","text":"https://secwatch.observer/filing/0000950170-23-000612.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023000612/0000950170-23-000612-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023000612/mrai-20230110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:15:17.788107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a34d6989f9f422e74309782ceec9de08c008225c","claim":"Marpai, Inc. completed an acquisition involving Maestro Health, LLC for Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., Seaview Re Holdings Inc., and AXA S.A. (closed 2022-11-01).","evidence_excerpt":"On November 1, 2022, Marpai, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Report”) to report the Company’s consummation of Maestro Health, LLC (“Maestro Health”), a Delaware limited liability company, pursuant to the terms of the Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., a Delaware corporation, Seaview Re Holdings Inc., a Delaware corporation, and AXA S.A., a French société anonyme.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023000612/0000950170-23-000612-index.htm","confidence":1.0,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Maestro Health, LLC"},{"label":"Consideration","value":"Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., Seaview Re Holdings Inc., and AXA S.A."},{"label":"Closing","value":"2022-11-01"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}